Substance | Condition | Seq | Src | PMID | Dtl | Title |
Haritaki | Alzheimer's Disease | 3 | PM | 35696798 | 📋 | Autophagy activation by Terminalia chebula Retz. reduce Aβ generation by shifting APP processing toward non-amyloidogenic pathway in APPswe transgenic SH-SY5Y cells |
Haritaki | Alzheimer's Disease | 2 | PM | 33307058 | 📋 | Protective effect of Terminalia chebula Retz. extract against Aβ aggregation and Aβ-induced toxicity in Caenorhabditis elegans |
Haritaki | Alzheimer's Disease | 1 | PM | 30414087 | 📋 | Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight Into Therapeutic Potential to Alleviate Alzheimer's Neuropathology |
Haritaki | Alzheimer's Disease | 4 | PM | 28638863 | 📋 | NEUROPROTECTIVE EFFECT OF TERMINALIA CHEBULA EXTRACTS AND ELLAGIC ACID IN PC12 CELLS |
Haritaki | Anxiety | 1 | PM | 37493534 | 📋 | Comparative effects of the alcoholic extract of Terminalia chebula and crocin on stress‑induced anxiety‑like behavior and memory impairment in male rats |
Haritaki | Depression | 1 | PM | 34765513 | 📋 | Anxiolytic-like and antidepressant-like effects of ethanol extract of Terminalia chebula in mice |
Haritaki | Diabetic Encephalopathy | 1 | PM | 38329710 | 📋 | Evaluation of the biological efficiency of Terminalia chebula fruit extract against neurochemical changes induced in brain of diabetic rats: an epigenetic study |
Haritaki | Schizophrenia | 1 | PM | 34814232 | 📋 | Evaluating the effect of black myrobalan on cognitive, positive, and negative symptoms in patients with chronic schizophrenia: A randomized, double-blind, placebo-controlled trial |